Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer. [electronic resource]
Producer: 20110518Description: 206-14 p. digitalISSN:- 1879-0852
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Colonic Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Irinotecan
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Rectal Neoplasms -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.